December 2011 Newsletter

December 20, 2011:

US IOL Procedures Climb by 2.5 Percent in Q3-2011

Overall, IOL surgery climbed 2.5 percent in Q3-2011 with premium procedures again posting double-digit growth.

December 20, 2011:

IVT Injections Continue to Drive US Retinal Procedures Higher in Q3-2011

In 2011’s third quarter, total retinal procedure volume rose by more than 11 percent year over year, as IVT injections surged.

December 20, 2011:

Dry Eye Products Market Positioned for Steady Growth

The global market in dry eye products will see steady, if modest, growth through 2016, much of which will be driven by aging, increased affluence, and access to health care in the developing world.

December 20, 2011:

Regeneron & Bayer Release Eylea’s Two-Year Phase III Study Results

Regeneron/Bayer released integrated two-year results for Eylea in wet AMD in the VIEW studies. VA gains were mostly maintained, but a PRN protocol proved less effective than more regular dosing.

December 20, 2011:

December 2011 News Briefs

This month's news includes the latest from Avedro, Bausch & Lomb, Laboratoria Pfortner Cornealent SACIF, Waicon, Regeneron, Bayer HealthCare, Alcon and NovaBay Pharmaceuticals.

December 20, 2011:

Q3-2011 US Refractive Surgery Recedes Slightly

After three quarters with procedures inching higher, refractive surgery dips slightly.

Social media